Literature DB >> 30248673

Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms.

Eric Baudin1, Aimee R Hayes2, Jean-Yves Scoazec3, Pier Luigi Filosso4, Eric Lim5, Gregory Kaltsas6, Andrea Frilling7, Jie Chen8, Beata Kos-Kudła9, Vera Gorbunova10, Bertram Wiedenmann11, Els Nieveen van Dijkum12, Jaroslaw B Ćwikła13, Jenny Falkerby14, Juan W Valle15, Matthew H Kulke16, Martyn E Caplin17.   

Abstract

Pulmonary carcinoids (PCs) display the common features of all well-differentiated neuroendocrine neoplasms (NEN) and are classified as low- and intermediate-grade malignant tumours (i.e., typical and atypical carcinoid, respectively). There is a paucity of randomised studies dedicated to advanced PCs and management principles are drawn from the larger gastroenteropancreatic NEN experience. There is growing evidence that NEN anatomic subgroups have different biology and different responses to treatment and, therefore, should be investigated as separate entities in clinical trials. In this review, we discuss the existing evidence and limitations of tumour classification, diagnostics and staging, prognostication, and treatment in the setting of PC, with focus on unmet medical needs and directions for the future.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Bronchial carcinoid tumours; NET; Neuroendocrine neoplasms; Pulmonary carcinoids

Year:  2018        PMID: 30248673     DOI: 10.1159/000493980

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  7 in total

1.  Unmet Needs in the Field of Neuroendocrine Neoplasms of the Gastrointestinal Tract, Pancreas, and Respiratory System: Reports by the ENETS Group.

Authors:  Wouter W de Herder; Jaume Capdevila
Journal:  Neuroendocrinology       Date:  2018-12-05       Impact factor: 4.914

2.  Platin‑based chemotherapy does not improve survival in patients with non‑metastatic resected typical carcinoid tumors.

Authors:  Ahmet Bilgehan Sahin; Huseyin Melek; Birol Ocak; Sibel Oyucu Orhan; Buket Erkan; Burcu Caner; Adem Deligonul; Erdem Cubukcu; Ahmet Sami Bayram; Elif Ulker Akyildiz; Turkkan Evrensel
Journal:  Mol Clin Oncol       Date:  2022-08-09

3.  Study on the prognosis, immune and drug resistance of m6A-related genes in lung cancer.

Authors:  Yang Yang; Zhouyao Qian; Mingyang Feng; Weiting Liao; Qiuji Wu; Feng Wen; Qiu Li
Journal:  BMC Bioinformatics       Date:  2022-10-19       Impact factor: 3.307

Review 4.  Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era.

Authors:  Víctor Rodriguez-Freixinos; Jaume Capdevila; Marianne Pavel; Alia Thawer; Eric Baudin; Dermot O'Toole; Ken Herrmann; Staffan Welin; Simona Grozinsky-Glasberg; Wouter W de Herder; Juan W Valle; Jackie Herman; Teodora Kolarova; Catherine Bouvier; Massimo Falconi; Diego Ferone; Simron Singh
Journal:  Eur J Cancer       Date:  2020-12-25       Impact factor: 9.162

Review 5.  Morphologic and molecular classification of lung neuroendocrine neoplasms.

Authors:  Jasna Metovic; Giuseppe Pelosi; Marco Barella; Fabrizio Bianchi; Paul Hofman; Veronique Hofman; Myriam Remmelink; Izidor Kern; Lina Carvalho; Linda Pattini; Angelica Sonzogni; Giulia Veronesi; Sergio Harari; Fabien Forest; Mauro Papotti
Journal:  Virchows Arch       Date:  2021-01-21       Impact factor: 4.064

6.  Prognostic significance of laterality in lung neuroendocrine tumors.

Authors:  Anna La Salvia; Irene Persano; Alessandra Siciliani; Monica Verrico; Massimiliano Bassi; Roberta Modica; Alessandro Audisio; Isabella Zanata; Beatrice Trabalza Marinucci; Elena Trevisi; Giulia Puliani; Maria Rinzivillo; Elena Parlagreco; Roberto Baldelli; Tiziana Feola; Franz Sesti; Paola Razzore; Rossella Mazzilli; Massimiliano Mancini; Francesco Panzuto; Marco Volante; Elisa Giannetta; Carmen Romero; Marialuisa Appetecchia; Andrea Isidori; Federico Venuta; Maria Rosaria Ambrosio; Maria Chiara Zatelli; Mohsen Ibrahim; Annamaria Colao; Maria Pia Brizzi; Rocío García-Carbonero; Antongiulio Faggiano
Journal:  Endocrine       Date:  2022-03-18       Impact factor: 3.925

7.  NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids.

Authors:  Irene Gagliardi; Mario Tarquini; Maria Rosaria Ambrosio; Elisa Giannetta; Patricia Borges de Souza; Roberta Gafà; Aldo Carnevale; Paola Franceschetti; Maria Chiara Zatelli
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-08       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.